| |
 |
ARTICLES 
|
|
| Three stakes in hydrazine sulfate's heart, but questionable cancer remedies, like vampires, always rise again |
| V Herbert |
|
JCO Jun 1 1994: 1107–1108.
[PDF]
|
 |
| AIDS-related Kaposi's sarcoma: still a problem, still an opportunity |
| DW Northfelt |
|
JCO Jun 1 1994: 1109–1110.
[PDF]
|
|
|
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small- cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B |
| |
MP Kosty, SB Fleishman, JE Herndon, 2nd, K Coughlin, AB Kornblith, A Scalzo, JC Morris, J Mortimer, and MR Green |
| |
JCO Jun 1 1994: 1113–1120.
[Abstract]
[PDF]
|
|
|
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer |
| |
CL Loprinzi, SA Kuross, JR O'Fallon, DH Gesme, Jr, JB Gerstner, RM Rospond, CD Cobau, and RM Goldberg |
| |
JCO Jun 1 1994: 1121–1125.
[Abstract]
[PDF]
|
|
|
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer |
| |
CL Loprinzi, RM Goldberg, JQ Su, JA Mailliard, SA Kuross, AW Maksymiuk, JW Kugler, JR Jett, C Ghosh, and DM Pfeifle |
| |
JCO Jun 1 1994: 1126–1129.
[Abstract]
[PDF]
|
|
|
Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma |
| |
SC Remick, M Reddy, D Herman, C Grace, G Harper, K Willis, B Candon, J Horton, and JC Ruckdeschel |
| |
JCO Jun 1 1994: 1130–1136.
[Abstract]
[PDF]
|
|
|
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group |
| |
V Bramwell, J Rouesse, W Steward, A Santoro, H Schraffordt-Koops, J Buesa, W Ruka, J Priario, T Wagener, and M Burgers |
| |
JCO Jun 1 1994: 1137–1149.
[Abstract]
[PDF]
|
|
|
A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk |
| |
PW Pisters, LB Harrison, JM Woodruff, JJ Gaynor, and MF Brennan |
| |
JCO Jun 1 1994: 1150–1155.
[Abstract]
[PDF]
|
|
|
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma |
| |
V Rusch, L Saltz, E Venkatraman, R Ginsberg, P McCormack, M Burt, M Markman, and D Kelsen |
| |
JCO Jun 1 1994: 1156–1163.
[Abstract]
[PDF]
|
|
|
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group |
| |
Sr Loehrer PJ, K Kim, SC Aisner, R Livingston, LH Einhorn, D Johnson, and R Blum |
| |
JCO Jun 1 1994: 1164–1168.
[Abstract]
[PDF]
|
|
|
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study |
| |
WS Velasquez, P McLaughlin, S Tucker, FB Hagemeister, F Swan, MA Rodriguez, J Romaguera, E Rubenstein, and F Cabanillas |
| |
JCO Jun 1 1994: 1169–1176.
[Abstract]
[PDF]
|
|
|
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma |
| |
AZ Rohatiner, PW Johnson, CG Price, SJ Arnott, JA Amess, AJ Norton, E Dorey, K Adams, JS Whelan, and J Matthews |
| |
JCO Jun 1 1994: 1177–1184.
[Abstract]
[PDF]
|
|
|
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study |
| |
AL Cheng, IJ Su, CC Chen, HF Tien, JD Lay, BR Chen, YS Pu, RL Hong, MC Shen, and CH Wang |
| |
JCO Jun 1 1994: 1185–1192.
[Abstract]
[PDF]
|
|
|
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts |
| |
S Welt, CR Divgi, AM Scott, P Garin-Chesa, RD Finn, M Graham, EA Carswell, A Cohen, SM Larson, and LJ Old |
| |
JCO Jun 1 1994: 1193–1203.
[Abstract]
[PDF]
|
|
|
Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival |
| |
YZ Patt, C Charnsangavej, B Yoffe, R Smith, D Lawrence, V Chuang, H Carrasco, M Roh, J Chase, and H Fischer |
| |
JCO Jun 1 1994: 1204–1211.
[Abstract]
[PDF]
|
|
|
Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy |
| |
A Gajjar, RK Mulhern, RL Heideman, RA Sanford, EC Douglass, EH Kovnar, JA Langston, JJ Jenkins, and LE Kun |
| |
JCO Jun 1 1994: 1212–1216.
[Abstract]
[PDF]
|
|
|
Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Societe Francaise de Greffe de Moelle |
| |
G Michel, E Gluckman, H Esperou-Bourdeau, J Reiffers, JL Pico, P Bordigoni, I Thuret, D Blaise, F Bernaudin, and JP Jouet |
| |
JCO Jun 1 1994: 1217–1222.
[Abstract]
[PDF]
|
|
|
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group |
| |
W Siegert, J Beyer, I Strohscheer, H Baurmann, H Oettle, J Zingsem, R Zimmermann, C Bokemeyer, HJ Schmoll, and D Huhn |
| |
JCO Jun 1 1994: 1223–1231.
[Abstract]
[PDF]
|
|
|
Phase II trial of docetaxel in patients with stage III and IV non-small- cell lung cancer |
| |
PA Francis, JR Rigas, MG Kris, KM Pisters, JP Orazem, KJ Woolley, and RT Heelan |
| |
JCO Jun 1 1994: 1232–1237.
[Abstract]
[PDF]
|
|
|
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer |
| |
FV Fossella, JS Lee, WK Murphy, SM Lippman, M Calayag, A Pang, M Chasen, DM Shin, B Glisson, and S Benner |
| |
JCO Jun 1 1994: 1238–1244.
[Abstract]
[PDF]
|
|
|
Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor |
| |
CR Nichols, EP Fox, BJ Roth, SD Williams, PJ Loehrer, and LH Einhorn |
| |
JCO Jun 1 1994: 1245–1250.
[Abstract]
[PDF]
|
|
|
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer |
| |
RL Krigel, CS Palackdharry, K Padavic, N Haas, D Kilpatrick, C Langer, and R Comis |
| |
JCO Jun 1 1994: 1251–1258.
[Abstract]
[PDF]
|
|
|
Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen |
| |
AL Jones, IE Smith, ME O'Brien, D Talbot, G Walsh, F Ramage, H Robertshaw, and S Ashley |
| |
JCO Jun 1 1994: 1259–1265.
[Abstract]
[PDF]
|
|
|
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study |
| |
PC Clahsen, CJ van de Velde, JP Julien, JL Floiras, and FY Mignolet |
| |
JCO Jun 1 1994: 1266–1271.
[Abstract]
[PDF]
|
|
|
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients |
| |
JL Abbruzzese, MC Abbruzzese, KR Hess, MN Raber, R Lenzi, and P Frost |
| |
JCO Jun 1 1994: 1272–1280.
[Abstract]
[PDF]
|
|
|
Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4- (phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents |
| |
LJ Brandes, KJ Simons, SP Bracken, and RC Warrington |
| |
JCO Jun 1 1994: 1281–1290.
[Abstract]
[PDF]
|
|
|
Relationship between fluorouracil systemic exposure and tumor response and patient survival |
| |
G Milano, MC Etienne, N Renee, A Thyss, M Schneider, A Ramaioli, and F Demard |
| |
JCO Jun 1 1994: 1291–1295.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials |
| |
S Rajagopal, PJ Goodman, and IF Tannock |
| |
JCO Jun 1 1994: 1296–1304.
[Abstract]
[PDF]
|
|
|
The take-home message: patients prefer consultation audiotapes to summary letters |
| |
MH Tattersall, PN Butow, AM Griffin, and SM Dunn |
| |
JCO Jun 1 1994: 1305–1311.
[Abstract]
[PDF]
|
|
|
Management of adult acute lymphocytic leukemia: present issues and key challenges |
| |
A Preti and HM Kantarjian |
| |
JCO Jun 1 1994: 1312–1322.
[Abstract]
[PDF]
|
|
|
Treatment of hepatocellular carcinoma: too many options? |
| |
AP Venook |
| |
JCO Jun 1 1994: 1323–1334.
[Abstract]
[PDF]
|
|
| Adjuvant therapy with fluorouracil and levamisole and liver ultrasound mimicking liver metastases |
| W Kwan, GA Bjarnason, and P Hamilton |
|
JCO Jun 1 1994: 1335–1336.
[PDF]
|
|
| Gallium scans for residual Hodgkin's disease |
| GH Goldsmith, Jr |
|
JCO Jun 1 1994: 1336a.
[PDF]
|
|
| Combination chemotherapy for metastatic melanoma: the importance of tamoxifen |
| PB Chapman |
|
JCO Jun 1 1994: 1336b–1337.
[PDF]
|
|
